Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Probabilistic dose-response modeling: case study using dichloromethane PBPK model results.

Dale J Marino1, Thomas B Starr

  • 1Health, Safety and Environment, Eastman Kodak Company, 1999 Lake Avenue, Rochester, NY 14650, USA. dmarino@CRAworld.com

Regulatory Toxicology and Pharmacology : RTP
|October 24, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Review of Stable Isotope Labeling and Mass Spectrometry Methods to Distinguish Exogenous from Endogenous DNA Adducts and Improve Dose-Response Assessments.

Chemical research in toxicology·2021
Same author

The bottom-up approach to bounding potential low-dose cancer risks from formaldehyde: An update.

Regulatory toxicology and pharmacology : RTP·2016
Same author

Formation, Accumulation, and Hydrolysis of Endogenous and Exogenous Formaldehyde-Induced DNA Damage.

Toxicological sciences : an official journal of the Society of Toxicology·2015
Same author

Response to Crump et al.

Regulatory toxicology and pharmacology : RTP·2014
Same author

Vanadium pentoxide: risk assessment implications of a treatment- but not dose-related tumorigenic response in B6C3F1 mice.

Regulatory toxicology and pharmacology : RTP·2014
Same author

A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and cancer risk in humans.

Critical reviews in toxicology·2014
Same journal

Cardiovascular toxicity as a globally harmonized system hazard trait: The evidence and the path forward.

Regulatory toxicology and pharmacology : RTP·2026
Same journal

The NTP Chronic Inhalation Study Does Not Support an Inherent Lung Cancer Hazard of Talc: Implications of Lung Particle Overload and Maximum Tolerated Dose.

Regulatory toxicology and pharmacology : RTP·2026
Same journal

Consideration of Carcinogenicity and Mode of Action Information by an Independent Expert Panel to Support Derivation of No-Significant-Risk-Level Values for Vinyl Acetate Monomer.

Regulatory toxicology and pharmacology : RTP·2026
Same journal

Which carcinogenicity study should I use? Automated identification of reliable studies.

Regulatory toxicology and pharmacology : RTP·2026
Same journal

Adoption of artificial intelligence in drug review across the lifecycle: Transformation of regulatory decision-making.

Regulatory toxicology and pharmacology : RTP·2026
Same journal

Cardiovascular outcomes following intrauterine and lactational exposure to cyantraniliprole in male Wistar rats.

Regulatory toxicology and pharmacology : RTP·2026
See all related articles

This study found that using probabilistic modeling for dichloromethane (DCM) risk assessment in mice did not significantly alter unit risk factor (URF) calculations compared to deterministic methods. Results show consistent variability across different modeling approaches for DCM cancer risk.

Area of Science:

  • Toxicology
  • Risk Assessment
  • Computational Biology

Background:

  • Dichloromethane (DCM) risk assessment involves understanding genetic influences on cancer. Physiologically Based Pharmacokinetic (PBPK) and dose-response modeling are key tools.
  • Previous assessments used deterministic PBPK modeling. This study explores the impact of probabilistic PBPK modeling, incorporating Bayesian techniques and human genetic polymorphisms.

Purpose of the Study:

  • To evaluate the impact of probabilistic versus deterministic PBPK and dose-response modeling in mice on determining unit risk factors (URFs) for DCM.
  • To compare variability in DCM risk estimates derived from different modeling techniques.

Main Methods:

  • Four probabilistic PBPK modeling cases were analyzed using Monte Carlo simulations (≥12,500 iterations) based on mouse bioassay data.

Related Experiment Videos

  • Dose metrics were calculated and combined with tumor incidence data for dose-response modeling to derive potency factors.
  • Probabilistic PBPK modeling in humans, including genetic polymorphisms, was used to determine URFs.

    • Main Results:

    • Probabilistic PBPK modeling in mice resulted in unit risk factors (URFs) with less than 10% difference compared to deterministic approaches.
    • Independent draws of PBPK inputs in probabilistic models slightly increased URFs.
    • Variability in DCM risk estimates was similar across different sources and modeling techniques, with 95th percentile-to-mean ratios ranging from 2.1 to 4.1.

    Conclusions:

    • Probabilistic PBPK and dose-response modeling in mice does not substantially alter DCM URFs compared to deterministic methods.
    • The choice of modeling approach (probabilistic vs. deterministic) and input variability has a limited impact on overall DCM risk estimates.
    • The study provides reasonable bounds for variability in probabilistic DCM risk assessments, highlighting consistency across diverse methodologies.